Navigation Links
5 from MD Anderson among first inaugurated to AACR Academy
Date:3/28/2013

retired as executive vice president and chief academic officer of MD Anderson and is now scientific director of the Cancer Prevention and Research Institute of Texas
  • John Mendelsohn, M.D., director, MD Anderson's Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy and president from 1996-2011, a time of tremendous growth and accomplishment for the institution. Also a pioneer in the field of targeted therapy, he and colleagues developed a monoclonal antibody that blocks activation of the epidermal growth factor receptor, which stimulates cancer. The first drug in its class, Erbitux is used to treat colon cancer and cancers of the head and neck.
  • Louise Strong, M.D., professor and Sue and Radcliffe Killam Chair, Department of Genetics, is an expert in cancer genetics and epidemiology. She has made seminal discoveries in the genetic bases of Wilms tumor, retinoblastoma and Li-Fraumeni syndrome, as well as of the cancer risk posed by inherited genetic mutations, including those in the tumor suppressor p53.

    "Selection to the AACR Academy is a richly deserved honor for MD Anderson's five Fellows, highlighting their indispensable contributions in cancer metastasis, personalized treatment, immunology, targeted therapy and cancer genetics," said Tom Buchholz, M.D., MD Anderson provost and executive vice president.

    "In addition to their scientific and medical achievements, all have exercised important leadership roles to support and encourage other scientists and physicians in their endeavors against cancer," Buchholz said. "Congratulations to the AACR for establishing this academy to spotlight those who have had major impact on the cause of understanding and curing cancer."

    Fidler, Hong, Kripke and Strong are all past presidents of AACR.

    106 inductees chosen from 69 institutions worldwide

    In announcing the new organization, the AACR noted the academy was created to recognize and ho
    '/>"/>


  • Contact: Scott Merville
    smerville@mdanderson.org
    713-792-0661
    University of Texas M. D. Anderson Cancer Center
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. UT MD Anderson study finds cancer related pain often undertreated
    2. University of Houston Graduate College of Social Work announces partnership with MD Anderson
    3. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
    4. UT MD Anderson study finds link between depressive symptoms and cancer survival
    5. UT MD Anderson Cancer Center launches unprecedented Moon Shots Program
    6. UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer
    7. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
    8. UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy
    9. UT MD Anderson scientists find protein that reins in runaway network
    10. MD Anderson study finds qigong improves quality of life for breast cancer patients
    11. Leading National Law Firm Anderson Kill & Olick Concludes NRRA Not Intended to Apply to Captive Insurance Companies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/22/2014)... 22 April 2014. The latest scientific advances and emerging ... Failure 2014, the main annual meeting of the Heart ... (ESC). Journalists will also hear breaking news on acute ... Heart Failure, which is part of the main congress. ... Athens, Greece, at the Megaron Athens International Conference Centre ...
    (Date:4/22/2014)... have demonstrated the first size-based form of chromatography ... of living cells. This unique physical approach to ... to whether a cell lives or dies, remains ... through conventional microscopy. , "We,ve developed membrane-embedded nanodot ... both probe and manipulate membrane assemblies, including signaling ...
    (Date:4/22/2014)... exposed to trauma, illness, alcohol or other drug abuse, ... brain cells that can go awry and activate conditions ... of autism. , Until now, it has been unclear ... a developing brain. Past studies have shown that when ... abuse or she experiences some trauma or illness, her ...
    (Date:4/22/2014)... fiction: In enemy territory, activate your cloaking device. And ... to the immune system. Now scientists at Harvard,s Wyss ... tactics to build the first DNA nanodevices that survive ... the way for smart DNA nanorobots that could use ... doctors can today; target drugs to tumors, or even ...
    (Date:4/22/2014)... can help doctors better identify patients who are at ... prevent the often deadly condition, suggest data from a ... Anesthesiology . , Affecting nearly 200,000 Americans a ... failure of the lungs caused by a number of ... infection. High-risk patients can develop ARDS after surgery. ARDS ...
    Breaking Medicine News(10 mins):Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:Life stressors trigger neurological disorders, researchers find 2Health News:Cloaked DNA nanodevices survive pilot mission 2Health News:Cloaked DNA nanodevices survive pilot mission 3Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2
    ... ... Victory: Cortical Concepts Wins ,Wharton Business Plan Competition Michelson Grand Prize with ,Device ... with Private Sales for Co-eds, , ... Philadelphia, PA (PRWEB) April 29, 2010 -- The ...
    ... ... of Science and Technology Policy, will bring together leaders in open innovation , ... Washington, DC (Vocus) -- ... Open Grant Making”, a public-private strategy session jointly hosted by the White House Office ...
    ... team of researchers at the University of Georgia and Emory ... from the National Institutes of Health to study the neurobiological ... relapse. "Drug abuse is closely linked to stress, ... is preventing the relapse caused by stress," said Philip Holmes, ...
    ... ... grant from the Ontario Ministry of Research and Innovation’s Biopharmaceutical Investment Program (BIP). ... facility in Mississauga, Ontario, Canada. , ... Toronto, ON (Vocus) April 30, 2010 -- Therapure Biopharma Inc. ...
    ... mutation impacts how the brain communicates with limbs, researcher says ... that causes a phenomenon known as mirror movements has been ... unable to move one side of their body without moving ... right hand, the same movement occurs unintentionally in the left ...
    ... ... Association, a non-profit organization, has developed a unique caregiver testing program to measure the ... and consumers. , ... Indianapolis, Ind. (Vocus) April 29, 2010 -- The National Private Duty Association (NPDA), a ...
    Cached Medicine News:Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 3Health News:Prize4Life Featured in Major Innovation/Prize National Conference 2Health News:Prize4Life Featured in Major Innovation/Prize National Conference 3Health News:UGA, Emory to study how exercise may prevent drug abuse relapse 2Health News:Therapure Awarded $4.2 Million BIP Grant from the Ontario Government 2Health News:Scientists Find Cause of Involuntary Mirror Movements 2Health News:Association Advocates Testing for Home Care Workers 2
    (Date:1/15/2014)... 15, 2014  Novation, the leading health care supply chain ... value-added reseller (VAR) national contracts that expand its portfolio ... at lower costs. These include manufacturer product and service ... assistance and ongoing IT consulting support. ...
    (Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
    (Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
    Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
    ... 2011 Columbia Laboratories, Inc. (Nasdaq: CBRX ... ), today announced the publication of Phase III PROCHIEVE® ... Ultrasound in Obstetrics & Gynecology , the leading peer-reviewed ... & Gynecology. The published results indicate ...
    ... SAN DIEGO, April 6, 2011 ... a leading global medical technology company, today announced ... of pharmaceutical waste, helping hospitals reduce cost, improve ... (Photo:   http://photos.prnewswire.com/prnh/20110406/LA78173 ) (Logo:   ...
    Cached Medicine Technology:Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 2Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 3Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 4Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 5Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 6Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 7Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 8CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste 2CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste 3
    30 cm - 11 3/4, packages 5 pcs....
    Outer diameter 8.0 mm, with graduation....
    Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
    Length-9 (229 mm) Tapered retractor blades....
    Medicine Products: